CYTOKINETICS INC (CYTK) › Cash & EquivalentsCYTOKINETICS INC (CYTK) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2008: $41.82M2009: $25.56M2010: $17.51M2011: $18.83M2012: $14.91M2013: $20.16M2014: $20.21M2015: $65.08M2016: $66.87M2017: $125.21M2018: $42.26M2019: $36.43M2020: $82.98M2021: $112.67M2022: $65.58M2023: $113.02M2024: $94.86M2025: $122.52M$122.52M2008Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$122.52M+29.2%2024$94.86M-16.1%2023$113.02M+72.3%2022$65.58M-41.8%2021$112.67M+35.8%2020$82.98M+127.8%2019$36.43M-13.8%2018$42.26M-66.3%2017$125.21M+87.2%2016$66.87M+2.8%2015$65.08M+221.9%2014$20.21M+0.3%2013$20.16M+35.2%2012$14.91M-20.8%2011$18.83M+7.5%2010$17.51M-31.5%2009$25.56M-38.9%2008$41.82M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share